Western blot analysis of lysates from A431 cells, treated with EGF 40muM 10' using Anti-EGFR Antibody. The right hand lane represents a negative control, where the antibody is blocked by the immunising peptide.
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using Anti-EGFR Antibody. The right hand panel represents a negative control, where the antibody was pre-incubated with the immunising peptide.
Receiver operating characteristic (ROC) curves comparing the diagnostic performance of direct and EF-lysed EGFR detection for distinguishing liver cirrhosis from healthy controls.
Figure 9f from Nusrat et al. (2026). Originally published in Science Direct, DOI: 10.1016/j.electacta.2026.149097. Reproduced under CC BY 4.0.
Recombinant human monoclonal antibody to EGFR for use as a research grade Panitumumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant chimeric monoclonal antibody to EGFR for use as a research grade Modotuximab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to EGFR for use as a research grade Panitumumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant chimeric monoclonal antibody to EGFR for use as a research grade Modotuximab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
![Flow Cytometry - Anti-EGFR Antibody [EGFR1] (A86603)](https://cdn.antibodies.com/image/catalog/86/A86603_1.jpg?profile=product_alternative)
